Compare XMTR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XMTR | RXRX |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2021 | 2021 |
| Metric | XMTR | RXRX |
|---|---|---|
| Price | $42.34 | $3.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $58.60 | $7.20 |
| AVG Volume (30 Days) | 1.2M | ★ 14.3M |
| Earning Date | 05-26-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.95 | 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $686,631,000.00 | $74,681,000.00 |
| Revenue This Year | $23.76 | $16.50 |
| Revenue Next Year | $18.38 | $66.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 25.87 | ★ 26.92 |
| 52 Week Low | $18.59 | $2.98 |
| 52 Week High | $73.87 | $7.18 |
| Indicator | XMTR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.69 | 40.80 |
| Support Level | $30.67 | $2.98 |
| Resistance Level | $50.22 | $5.12 |
| Average True Range (ATR) | 4.02 | 0.21 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 14.88 | 20.89 |
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.